Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Northrim BanCorp
NRIM
$601M
| $2.79M | ﹤0.01% |
372,000
-98,400
| -21% | -$729K |
|
2052
Safe Bulkers
SB
$781M
| $2.79M | ﹤0.01% |
1,269,600
+977,900
| +335% | +$1.51M |
|
2053
Tactile Systems Technology
TCMD
$537M
| $2.79M | ﹤0.01% |
+147,200
| New | +$2.5M |
|
|
EXAC
2054
DELISTED
Exactech Inc
EXAC
| $2.79M | ﹤0.01% |
110,600
+4,900
| +5% | +$126K |
|
|
BKS
2055
DELISTED
Barnes & Noble
BKS
| $2.79M | ﹤0.01% |
301,103
+170,437
| +130% | +$1.7M |
|
|
WFBI
2056
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $2.78M | ﹤0.01% |
99,235
+15,500
| +19% | +$434K |
|
2057
Genie Energy
GNE
$386M
| $2.77M | ﹤0.01% |
382,876
+16,079
| +4% | +$94.2K |
|
|
TREC
2058
DELISTED
Trecora Resources
TREC
| $2.77M | ﹤0.01% |
249,500
+28,100
| +13% | +$346K |
|
2059
FTAI Aviation
FTAI
$22.2B
| $2.77M | ﹤0.01% |
217,400
-86,891
| -29% | -$1.1M |
|
2060
Republic Bancorp
RBCAA
$1.92B
| $2.77M | ﹤0.01% |
80,500
-2,300
| -3% | -$82.2K |
|
2061
Radcom
RDCM
$170M
| $2.76M | ﹤0.01% |
128,400
-78,300
| -38% | -$1.46M |
|
2062
State Street
STT
$52.2B
| $2.76M | ﹤0.01% |
34,631
-76,500
| -69% | -$6.07M |
|
|
ASRT
2063
DELISTED
Assertio
ASRT
| $2.74M | ﹤0.01% |
+3,641
| New | +$3.69M |
|
|
WSTC
2064
DELISTED
West Corporation
WSTC
| $2.74M | ﹤0.01% |
112,200
-59,300
| -35% | -$1.45M |
|
|
PTX
2065
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.74M | ﹤0.01% |
740,650
+47,700
| +7% | +$150K |
|
|
PCOM
2066
DELISTED
Points.com Inc. Common Shares
PCOM
| $2.74M | ﹤0.01% |
354,700
+7,140
| +2% | +$53.6K |
|
|
AMID
2067
DELISTED
American Midstream Partners, LP
AMID
| $2.73M | ﹤0.01% |
183,619
+56,734
| +45% | +$942K |
|
2068
NRC Health Common Stock
NRC
$471M
| $2.73M | ﹤0.01% |
138,400
+11,200
| +9% | +$207K |
|
2069
Escalade
ESCA
$287M
| $2.72M | ﹤0.01% |
210,800
-9,200
| -4% | -$120K |
|
|
TAX
2070
DELISTED
Liberty Tax, Inc. Class A
TAX
| $2.72M | ﹤0.01% |
190,752
-58,748
| -24% | -$835K |
|
2071
Standard BioTools
LAB
$294M
| $2.71M | ﹤0.01% |
476,400
+25,100
| +6% | +$159K |
|
|
HOLI
2072
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.71M | ﹤0.01% |
160,053
+103,848
| +185% | +$1.82M |
|
2073
Espey Mfg & Electronics Corp
ESP
$193M
| $2.7M | ﹤0.01% |
117,500
+2,400
| +2% | +$59.7K |
|
|
KONA
2074
DELISTED
Kona Grill, Inc.
KONA
| $2.7M | ﹤0.01% |
429,059
+11,100
| +3% | +$89.5K |
|
2075
BlackLine
BL
$1.82B
| $2.7M | ﹤0.01% |
+90,795
| New | +$2.55M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.